Do You Have Rheumatoid Arthritis? Heartland Research is conducting a research study of an oral investigational medication for people with Rheumatoid Arthritis For qualification information and study related compensation; https://heartlandresearch.com/studies/rheumatoid-arthritis-research-study/
Self-injectable Tocilizumab was approved by the EU late April 2014 to specifically treat adult patients with moderate or severe Rheumatoid arthritis (RA) who have failed to respond to other medications or who are intolerant to prior treatments. RoACTEMRA is the 1st and only anti IL-6 receptor biologic offered as both an IV treatment and a subcutaneous injection to be used alone or in combination with Methotrexate. The approval was based on two Phase 3 trials coined BREVACTA and SUMMACTA.